ESMO (European Society for Medical Oncology) shared a post on LinkedIn:
“How can multimodal AI advance Precision Oncology and support clinical decision-making? At the ESMO AI and Digital Oncology Congress 2025, the session ‘Multimodal AI for clinical decision support’ will explore:
- Multimodal AI assistants for molecular tumour boards
- Next-generation real-world data for decision support systems
- Multimodal explainability for patients and doctors
- Is more always better? Challenges in multimodal integration
Discover the Congress pages.”
More posts featuring ESMO.